Genmab A/S

Genmab provides only a brief indication that lobbying-related activity falls under board-level oversight, stating that its Nominating and Corporate Governance Committee "oversee[s] the Company's policies and practices regarding philanthropic and political activities" and more broadly "administers and oversees all aspects of Genmab's efforts related to corporate governance, corporate social responsibility (CSR), ESG and sustainability" as well as "climate related financial risks and opportunities and Genmab's climate strategy." These excerpts identify a formal body that is informed "at least once a year" and therefore imply some oversight, yet the company does not disclose any procedure for reviewing or aligning its direct or indirect lobbying with its climate strategy, makes no reference to trade-association assessments, and provides no detail on monitoring, escalation, or corrective actions. Because the disclosure names an oversight body but lacks any description of concrete alignment mechanisms, audits, or processes, this indicates limited governance of climate-related lobbying activities.